Trials / Recruiting
RecruitingNCT07203482
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
A Single-center Observational Study of Clinical Outcomes of Clinically Localized Prostate Cancer Undergoing HIFU Therapy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- Male
- Age
- 40 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this research database is to prospectively collect data to assess treatment related complications, oncologic outcomes and urinary/sexual function, and identify predictors of complications, oncological control and functional outcomes after Hhigh-intensity focused ultrasound (HIFU) ablation of prostate cancer with the intent to guide further research and improve patient care. We will include subjects who will have a HIFU procedure performed from all Sub-Investigators included in the study.
Conditions
Timeline
- Start date
- 2024-05-16
- Primary completion
- 2030-12-31
- Completion
- 2050-12-31
- First posted
- 2025-10-02
- Last updated
- 2025-10-02
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07203482. Inclusion in this directory is not an endorsement.